Empagliflozin Monotherapy for 12 Weeks Improves Glycemic Control in Japanese Patients With Type 2 Diabetes (T2DM)

被引：0

|

作者：

Kadowaki, Takashi

Haneda, Masakazu

Inagaki, Nobuya

Taniguchi, Atsushi

Sakamoto, Masashi

Koiwai, Kazuki

Rattunde, Henning

Woerle, Hans J.

Broedl, Uli C.

机构：

来源：

DIABETES | 2013年 / 62卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1144-P

引用

下载

收藏

页码：A297 / A298

页数：2

相关论文

共 50 条

[31] Ipragliflozin improves glycemic control in Japanese patients with type 2 diabetes mellitus: the BRIGHTEN study: BRIGHTEN: double-blind randomized study of ipragliflozin to show its efficacy as monotherapy in T2DM patients
Kashiwagi A.
Kazuta K.
Takinami Y.
Yoshida S.
Utsuno A.
Nagase I.
Diabetology International, 2015, 6 (1) : 8 - 18
[32] Gastric electrical stimulation (TANTALUS-TM) improves glycemic control in morbidly obese patients with type 2 diabetes (T2DM)
Ludvik, Bernhard
Prager, Gerhard
Weiner, Rudolf
Rosak, Christoph
DIABETES, 2007, 56 : A164 - A164
[33] Sitagliptin added to ongoing treatment with glimepiride improved glycemic control and was well tolerated in Japanese patients with type 2 diabetes (T2DM)
Tajima, Naoko
Kadowaki, Takashi
Odawara, Masato
Nishii, Mikio
Nonaka, Kenji
Stein, Peter P.
DIABETES, 2008, 57 : A589 - A589
[34] Sitagliptin added to ongoing treatment with metformin improved glycemic control and was well tolerated in Japanese patients with type 2 diabetes (T2DM)
Kadowaki, Takashi
Tajima, Naoko
Odawara, Masato
Nishii, Mikio
Nonaka, Kenji
Stein, Peter P.
DIABETES, 2008, 57 : A589 - A590
[35] NETWORK META-ANALYSIS TO ASSESS THE RELATIVE EFFICACY OF EMPAGLIFLOZIN MONOTHERAPY OVER 24, 52, AND 76 WEEKS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM)
Daacke, I
Batson, S.
Burton, H. E.
Tebboth, A.
VALUE IN HEALTH, 2016, 19 (07) : A667 - A667
[36] Saxagliptin Improves Glycemic Control and Is Well Tolerated in Patients with Type 2 Diabetes Mellitus (T2DM) and Renal Impairment Compared with Placebo
Owens, David R.
Swallow, Ros
Jones, Peter
Dugi, Klaus A.
Woerle, Hans-Juergen
DIABETES, 2010, 59 : A149 - A150
[37] Sitagliptin added to ongoing treatment with pioglitazone improved glycemic control and was well tolerated in Japanese patients with type 2 diabetes (T2DM)
Kashiwagi, Atsunori
Tajima, Naoko
Kadowaki, Takashi
Nonaka, Kenji
Moto, Tarooka
Okuyama, Kotoba
Nishii, Mikio
Stein, Peter R.
DIABETES, 2008, 57 : A590 - A590
[38] Colesevelarn HCI improves glycemic control in type 2 diabetes mellitus (T2DM) subjects managed with insulin therapy
Goldberg, Ronald B.
Truitt, Kenneth
CIRCULATION, 2006, 114 (18) : 306 - 306
[39] Colesevelam HCl improves glycaemic control in patients with type 2 diabetes (T2DM): a pilot study
Jones, M.
Schwartz, S.
Zieve, F.
Kalin, M.
DIABETOLOGIA, 2006, 49 : 746 - 747
[40] The effects of gastric electrical stimulation (TANTALUS®) on glycemic control in obese patients with type 2 diabetes (T2DM)
Bohdjalian, Arthur
Rosak, Ch
Jung, R.
Schramm, M.
Weiner, R.
Ludvik, B.
Prager, G.
OBESITY SURGERY, 2007, 17 (08) : 1055 - 1055

← 1 2 3 4 5 →